市場調查報告書

內分泌檢查的全球市場

Endocrine Testing

出版商 Global Industry Analysts, Inc. 商品編碼 957014
出版日期 內容資訊 英文 415 Pages
商品交期: 最快1-2個工作天內
價格
內分泌檢查的全球市場 Endocrine Testing
出版日期: 2020年09月01日內容資訊: 英文 415 Pages
簡介

全球內分泌檢查的市場規模在2020年∼2027年的期間中預計將以6.5%的年複合成長率增長,從2020年的86億美元達到2027年133億美元的規模。市場區隔之一的雌二醇(E2)檢驗在分析期間結束前預測將以7%的年複合成長率增長,並達到26億美元的規模。

本報告提供全球內分泌檢查市場的相關調查,提供市場佔有率,趨勢和預測,成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例
  • AB SCIEX LLC
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Alfa Aesar, A Thermo Fisher Scientific Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin, Inc.
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings (LabCorp)
  • Ortho-Clinical Diagnostics
  • Quest Technology (S) Pte Ltd.
  • Sysmex Corporation
  • Teleflex Inc.

目錄

I. 簡介,調查手法 、 調查範圍

II. 摘要整理

  • 市場概要
    • 競爭的市場佔有率
    • 競爭的市場佔有率方案
    • Covid-19影響與全球景氣衰退
  • 主要企業
  • 趨勢與成長要素
  • 全球市場預測

III. 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

IV. 競爭

  • 企業簡介:31公司
目錄
Product Code: MCP11785

Global Endocrine Testing Market to Reach $13.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Endocrine Testing estimated at US$8.6 Billion in the year 2020, is projected to reach a revised size of US$13.3 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Estradiol (E2) Testing, one of the segments analyzed in the report, is projected to record a 7% CAGR and reach US$2.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Follicle Stimulating Hormone (FSH) Testing segment is readjusted to a revised 6.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 9.9% CAGR

The Endocrine Testing market in the U.S. is estimated at US$2.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2027 trailing a CAGR of 9.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Human Chorionic Gonadotropin (hCG) Hormone Testing Segment to Record 5.1% CAGR

In the global Human Chorionic Gonadotropin (hCG) Hormone Testing segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$320.7 Million in the year 2020 will reach a projected size of US$442.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.8 Billion by the year 2027, while Latin America will expand at a 6.2% CAGR through the analysis period. We bring years of research experience to this 5th edition of our report. The 415-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • AB SCIEX LLC
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Alfa Aesar, A Thermo Fisher Scientific Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin, Inc.
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings (LabCorp)
  • Ortho-Clinical Diagnostics
  • Quest Technology (S) Pte Ltd.
  • Sysmex Corporation
  • Teleflex Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Endocrine Testing Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Endocrine Testing Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 2: Endocrine Testing Global Retrospective Market Scenario in US$ Million by Region/Country: 2012
    • TABLE 3: Endocrine Testing Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS
    • TABLE 4: Insulin Testing (Test Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 5: Insulin Testing (Test Type) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 6: Insulin Testing (Test Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 7: Follicle Stimulating Hormone (FSH) Testing (Test Type) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 8: Follicle Stimulating Hormone (FSH) Testing (Test Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 9: Follicle Stimulating Hormone (FSH) Testing (Test Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 10: Human Chorionic Gonadotropin (hCG) Hormone Testing (Test Type) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 11: Human Chorionic Gonadotropin (hCG) Hormone Testing (Test Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 12: Human Chorionic Gonadotropin (hCG) Hormone Testing (Test Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 13: Luteinizing Hormone (LH) Testing (Test Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 14: Luteinizing Hormone (LH) Testing (Test Type) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 15: Luteinizing Hormone (LH) Testing (Test Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 16: Dehydroepiandrosterone Sulfate (DHEAS) Testing (Test Type) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 17: Dehydroepiandrosterone Sulfate (DHEAS) Testing (Test Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 18: Dehydroepiandrosterone Sulfate (DHEAS) Testing (Test Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 19: Progesterone Testing (Test Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to
    • TABLE 20: Progesterone Testing (Test Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 21: Progesterone Testing (Test Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS
    • TABLE 22: Testosterone Testing (Test Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to
    • TABLE 23: Testosterone Testing (Test Type) Global Historic Demand in US$ Million by Region/Country: 2012 to
    • TABLE 24: Testosterone Testing (Test Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 25: Thyroid Stimulating Hormone (TSH) Testing (Test Type) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 26: Thyroid Stimulating Hormone (TSH) Testing (Test Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 27: Thyroid Stimulating Hormone (TSH) Testing (Test Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 28: Prolactin Testing (Test Type) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 29: Prolactin Testing (Test Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 30: Prolactin Testing (Test Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 31: Cortisol Testing (Test Type) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 32: Cortisol Testing (Test Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 33: Cortisol Testing (Test Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 34: Estradiol (E2) Testing (Test Type) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 35: Estradiol (E2) Testing (Test Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 36: Estradiol (E2) Testing (Test Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 37: Other Test Types (Test Type) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 38: Other Test Types (Test Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 39: Other Test Types (Test Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 40: Adrenal Disorders (Endocrine Disorders) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to
    • TABLE 41: Adrenal Disorders (Endocrine Disorders) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 42: Adrenal Disorders (Endocrine Disorders) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS
    • TABLE 43: Calcium Problems (Endocrine Disorders) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to
    • TABLE 44: Calcium Problems (Endocrine Disorders) Global Historic Demand in US$ Million by Region/Country: 2012 to
    • TABLE 45: Calcium Problems (Endocrine Disorders) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 46: Glucose (islet cells) Disorders (Endocrine Disorders) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 47: Glucose (islet cells) Disorders (Endocrine Disorders) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 48: Glucose (islet cells) Disorders (Endocrine Disorders) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 49: Male and Female Gonadal Problems (Endocrine Disorders) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 50: Male and Female Gonadal Problems (Endocrine Disorders) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 51: Male and Female Gonadal Problems (Endocrine Disorders) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 52: Heart Disorders (Endocrine Disorders) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 53: Heart Disorders (Endocrine Disorders) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 54: Heart Disorders (Endocrine Disorders) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 55: Hypertensive Disorders (Endocrine Disorders) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 56: Hypertensive Disorders (Endocrine Disorders) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 57: Hypertensive Disorders (Endocrine Disorders) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 58: Thyroid Disorders (Endocrine Disorders) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 59: Thyroid Disorders (Endocrine Disorders) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 60: Thyroid Disorders (Endocrine Disorders) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 61: Pituitary Disorders (Endocrine Disorders) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to
    • TABLE 62: Pituitary Disorders (Endocrine Disorders) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 63: Pituitary Disorders (Endocrine Disorders) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS
    • TABLE 64: Immunoassay Technology (Testing Technology) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to
    • TABLE 65: Immunoassay Technology (Testing Technology) Global Historic Demand in US$ Million by Region/Country: 2012 to
    • TABLE 66: Immunoassay Technology (Testing Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 67: Tandem Mass Spectrometry (Testing Technology) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 68: Tandem Mass Spectrometry (Testing Technology) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 69: Tandem Mass Spectrometry (Testing Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 70: Sensors Technology (Testing Technology) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 71: Sensors Technology (Testing Technology) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 72: Sensors Technology (Testing Technology) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 73: Monoclonal and Polyclonal Antibody Technology (Testing Technology) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 74: Monoclonal and Polyclonal Antibody Technology (Testing Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 75: Monoclonal and Polyclonal Antibody Technology (Testing Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 76: Clinical Chemistry Technology (Testing Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 77: Clinical Chemistry Technology (Testing Technology) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 78: Clinical Chemistry Technology (Testing Technology) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 79: Other Testing Technologies (Testing Technology) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 80: Other Testing Technologies (Testing Technology) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 81: Other Testing Technologies (Testing Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Endocrine Testing Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 82: United States Endocrine Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to
    • TABLE 83: Endocrine Testing Market in the United States by Test Type: A Historic Review in US$ Million for 2012
    • TABLE 84: United States Endocrine Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS
    • TABLE 85: United States Endocrine Testing Market Estimates and Projections in US$ Million by Endocrine Disorders: 2020 to
    • TABLE 86: Endocrine Testing Market in the United States by Endocrine Disorders: A Historic Review in US$ Million for 2012
    • TABLE 87: United States Endocrine Testing Market Share Breakdown by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 88: United States Endocrine Testing Market Estimates and Projections in US$ Million by Testing Technology: 2020 to
    • TABLE 89: Endocrine Testing Market in the United States by Testing Technology: A Historic Review in US$ Million for 2012
    • TABLE 90: United States Endocrine Testing Market Share Breakdown by Testing Technology: 2012 VS 2020 VS
  • CANADA
    • TABLE 91: Canadian Endocrine Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to
    • TABLE 92: Canadian Endocrine Testing Historic Market Review by Test Type in US$ Million: 2012
    • TABLE 93: Endocrine Testing Market in Canada: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and
    • TABLE 94: Canadian Endocrine Testing Market Estimates and Forecasts in US$ Million by Endocrine Disorders: 2020 to
    • TABLE 95: Canadian Endocrine Testing Historic Market Review by Endocrine Disorders in US$ Million: 2012
    • TABLE 96: Endocrine Testing Market in Canada: Percentage Share Breakdown of Sales by Endocrine Disorders for 2012, 2020, and
    • TABLE 97: Canadian Endocrine Testing Market Estimates and Forecasts in US$ Million by Testing Technology: 2020 to
    • TABLE 98: Canadian Endocrine Testing Historic Market Review by Testing Technology in US$ Million: 2012
    • TABLE 99: Endocrine Testing Market in Canada: Percentage Share Breakdown of Sales by Testing Technology for 2012, 2020, and
  • JAPAN
    • TABLE 100: Japanese Market for Endocrine Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020
    • TABLE 101: Endocrine Testing Market in Japan: Historic Sales Analysis in US$ Million by Test Type for the Period 2012
    • TABLE 102: Japanese Endocrine Testing Market Share Analysis by Test Type: 2012 VS 2020 VS
    • TABLE 103: Japanese Market for Endocrine Testing: Annual Sales Estimates and Projections in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 104: Endocrine Testing Market in Japan: Historic Sales Analysis in US$ Million by Endocrine Disorders for the Period 2012
    • TABLE 105: Japanese Endocrine Testing Market Share Analysis by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 106: Japanese Market for Endocrine Testing: Annual Sales Estimates and Projections in US$ Million by Testing Technology for the Period 2020
    • TABLE 107: Endocrine Testing Market in Japan: Historic Sales Analysis in US$ Million by Testing Technology for the Period 2012
    • TABLE 108: Japanese Endocrine Testing Market Share Analysis by Testing Technology: 2012 VS 2020 VS
  • CHINA
    • TABLE 109: Chinese Endocrine Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020
    • TABLE 110: Endocrine Testing Historic Market Analysis in China in US$ Million by Test Type: 2012
    • TABLE 111: Chinese Endocrine Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 112: Chinese Endocrine Testing Market Growth Prospects in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 113: Endocrine Testing Historic Market Analysis in China in US$ Million by Endocrine Disorders: 2012
    • TABLE 114: Chinese Endocrine Testing Market by Endocrine Disorders: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 115: Chinese Endocrine Testing Market Growth Prospects in US$ Million by Testing Technology for the Period 2020
    • TABLE 116: Endocrine Testing Historic Market Analysis in China in US$ Million by Testing Technology: 2012
    • TABLE 117: Chinese Endocrine Testing Market by Testing Technology: Percentage Breakdown of Sales for 2012, 2020, and
  • EUROPE
    • Market Facts & Figures
    • European Endocrine Testing Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 118: European Endocrine Testing Market Demand Scenario in US$ Million by Region/Country: 2020
    • TABLE 119: Endocrine Testing Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012
    • TABLE 120: European Endocrine Testing Market Share Shift by Region/Country: 2012 VS 2020 VS
    • TABLE 121: European Endocrine Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020
    • TABLE 122: Endocrine Testing Market in Europe in US$ Million by Test Type: A Historic Review for the Period 2012
    • TABLE 123: European Endocrine Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS
    • TABLE 124: European Endocrine Testing Market Estimates and Forecasts in US$ Million by Endocrine Disorders: 2020
    • TABLE 125: Endocrine Testing Market in Europe in US$ Million by Endocrine Disorders: A Historic Review for the Period 2012
    • TABLE 126: European Endocrine Testing Market Share Breakdown by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 127: European Endocrine Testing Market Estimates and Forecasts in US$ Million by Testing Technology: 2020
    • TABLE 128: Endocrine Testing Market in Europe in US$ Million by Testing Technology: A Historic Review for the Period 2012
    • TABLE 129: European Endocrine Testing Market Share Breakdown by Testing Technology: 2012 VS 2020 VS
  • FRANCE
    • TABLE 130: Endocrine Testing Market in France by Test Type: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 131: French Endocrine Testing Historic Market Scenario in US$ Million by Test Type: 2012
    • TABLE 132: French Endocrine Testing Market Share Analysis by Test Type: 2012 VS 2020 VS
    • TABLE 133: Endocrine Testing Market in France by Endocrine Disorders: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 134: French Endocrine Testing Historic Market Scenario in US$ Million by Endocrine Disorders: 2012
    • TABLE 135: French Endocrine Testing Market Share Analysis by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 136: Endocrine Testing Market in France by Testing Technology: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 137: French Endocrine Testing Historic Market Scenario in US$ Million by Testing Technology: 2012
    • TABLE 138: French Endocrine Testing Market Share Analysis by Testing Technology: 2012 VS 2020 VS
  • GERMANY
    • TABLE 139: Endocrine Testing Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020
    • TABLE 140: German Endocrine Testing Historic Market Analysis in US$ Million by Test Type: 2012
    • TABLE 141: German Endocrine Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS
    • TABLE 142: Endocrine Testing Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 143: German Endocrine Testing Historic Market Analysis in US$ Million by Endocrine Disorders: 2012
    • TABLE 144: German Endocrine Testing Market Share Breakdown by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 145: Endocrine Testing Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Testing Technology for the Period 2020
    • TABLE 146: German Endocrine Testing Historic Market Analysis in US$ Million by Testing Technology: 2012
    • TABLE 147: German Endocrine Testing Market Share Breakdown by Testing Technology: 2012 VS 2020 VS
  • ITALY
    • TABLE 148: Italian Endocrine Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020
    • TABLE 149: Endocrine Testing Historic Market Analysis in Italy in US$ Million by Test Type: 2012
    • TABLE 150: Italian Endocrine Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 151: Italian Endocrine Testing Market Growth Prospects in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 152: Endocrine Testing Historic Market Analysis in Italy in US$ Million by Endocrine Disorders: 2012
    • TABLE 153: Italian Endocrine Testing Market by Endocrine Disorders: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 154: Italian Endocrine Testing Market Growth Prospects in US$ Million by Testing Technology for the Period 2020
    • TABLE 155: Endocrine Testing Historic Market Analysis in Italy in US$ Million by Testing Technology: 2012
    • TABLE 156: Italian Endocrine Testing Market by Testing Technology: Percentage Breakdown of Sales for 2012, 2020, and
  • UNITED KINGDOM
    • TABLE 157: United Kingdom Market for Endocrine Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020
    • TABLE 158: Endocrine Testing Market in the United Kingdom: Historic Sales Analysis in US$ Million by Test Type for the Period 2012
    • TABLE 159: United Kingdom Endocrine Testing Market Share Analysis by Test Type: 2012 VS 2020 VS
    • TABLE 160: United Kingdom Market for Endocrine Testing: Annual Sales Estimates and Projections in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 161: Endocrine Testing Market in the United Kingdom: Historic Sales Analysis in US$ Million by Endocrine Disorders for the Period 2012
    • TABLE 162: United Kingdom Endocrine Testing Market Share Analysis by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 163: United Kingdom Market for Endocrine Testing: Annual Sales Estimates and Projections in US$ Million by Testing Technology for the Period 2020
    • TABLE 164: Endocrine Testing Market in the United Kingdom: Historic Sales Analysis in US$ Million by Testing Technology for the Period 2012
    • TABLE 165: United Kingdom Endocrine Testing Market Share Analysis by Testing Technology: 2012 VS 2020 VS
  • SPAIN
    • TABLE 166: Spanish Endocrine Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to
    • TABLE 167: Spanish Endocrine Testing Historic Market Review by Test Type in US$ Million: 2012
    • TABLE 168: Endocrine Testing Market in Spain: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and
    • TABLE 169: Spanish Endocrine Testing Market Estimates and Forecasts in US$ Million by Endocrine Disorders: 2020 to
    • TABLE 170: Spanish Endocrine Testing Historic Market Review by Endocrine Disorders in US$ Million: 2012
    • TABLE 171: Endocrine Testing Market in Spain: Percentage Share Breakdown of Sales by Endocrine Disorders for 2012, 2020, and
    • TABLE 172: Spanish Endocrine Testing Market Estimates and Forecasts in US$ Million by Testing Technology: 2020 to
    • TABLE 173: Spanish Endocrine Testing Historic Market Review by Testing Technology in US$ Million: 2012
    • TABLE 174: Endocrine Testing Market in Spain: Percentage Share Breakdown of Sales by Testing Technology for 2012, 2020, and
  • RUSSIA
    • TABLE 175: Russian Endocrine Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to
    • TABLE 176: Endocrine Testing Market in Russia by Test Type: A Historic Review in US$ Million for 2012
    • TABLE 177: Russian Endocrine Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS
    • TABLE 178: Russian Endocrine Testing Market Estimates and Projections in US$ Million by Endocrine Disorders: 2020 to
    • TABLE 179: Endocrine Testing Market in Russia by Endocrine Disorders: A Historic Review in US$ Million for 2012
    • TABLE 180: Russian Endocrine Testing Market Share Breakdown by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 181: Russian Endocrine Testing Market Estimates and Projections in US$ Million by Testing Technology: 2020 to
    • TABLE 182: Endocrine Testing Market in Russia by Testing Technology: A Historic Review in US$ Million for 2012
    • TABLE 183: Russian Endocrine Testing Market Share Breakdown by Testing Technology: 2012 VS 2020 VS
  • REST OF EUROPE
    • TABLE 184: Rest of Europe Endocrine Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020
    • TABLE 185: Endocrine Testing Market in Rest of Europe in US$ Million by Test Type: A Historic Review for the Period 2012
    • TABLE 186: Rest of Europe Endocrine Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS
    • TABLE 187: Rest of Europe Endocrine Testing Market Estimates and Forecasts in US$ Million by Endocrine Disorders: 2020
    • TABLE 188: Endocrine Testing Market in Rest of Europe in US$ Million by Endocrine Disorders: A Historic Review for the Period 2012
    • TABLE 189: Rest of Europe Endocrine Testing Market Share Breakdown by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 190: Rest of Europe Endocrine Testing Market Estimates and Forecasts in US$ Million by Testing Technology: 2020
    • TABLE 191: Endocrine Testing Market in Rest of Europe in US$ Million by Testing Technology: A Historic Review for the Period 2012
    • TABLE 192: Rest of Europe Endocrine Testing Market Share Breakdown by Testing Technology: 2012 VS 2020 VS
  • ASIA-PACIFIC
    • TABLE 193: Asia-Pacific Endocrine Testing Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 194: Endocrine Testing Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012
    • TABLE 195: Asia-Pacific Endocrine Testing Market Share Analysis by Region/Country: 2012 VS 2020 VS
    • TABLE 196: Endocrine Testing Market in Asia-Pacific by Test Type: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 197: Asia-Pacific Endocrine Testing Historic Market Scenario in US$ Million by Test Type: 2012
    • TABLE 198: Asia-Pacific Endocrine Testing Market Share Analysis by Test Type: 2012 VS 2020 VS
    • TABLE 199: Endocrine Testing Market in Asia-Pacific by Endocrine Disorders: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 200: Asia-Pacific Endocrine Testing Historic Market Scenario in US$ Million by Endocrine Disorders: 2012
    • TABLE 201: Asia-Pacific Endocrine Testing Market Share Analysis by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 202: Endocrine Testing Market in Asia-Pacific by Testing Technology: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 203: Asia-Pacific Endocrine Testing Historic Market Scenario in US$ Million by Testing Technology: 2012
    • TABLE 204: Asia-Pacific Endocrine Testing Market Share Analysis by Testing Technology: 2012 VS 2020 VS
  • AUSTRALIA
    • TABLE 205: Endocrine Testing Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020
    • TABLE 206: Australian Endocrine Testing Historic Market Analysis in US$ Million by Test Type: 2012
    • TABLE 207: Australian Endocrine Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS
    • TABLE 208: Endocrine Testing Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 209: Australian Endocrine Testing Historic Market Analysis in US$ Million by Endocrine Disorders: 2012
    • TABLE 210: Australian Endocrine Testing Market Share Breakdown by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 211: Endocrine Testing Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Testing Technology for the Period 2020
    • TABLE 212: Australian Endocrine Testing Historic Market Analysis in US$ Million by Testing Technology: 2012
    • TABLE 213: Australian Endocrine Testing Market Share Breakdown by Testing Technology: 2012 VS 2020 VS
  • INDIA
    • TABLE 214: Indian Endocrine Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to
    • TABLE 215: Indian Endocrine Testing Historic Market Review by Test Type in US$ Million: 2012
    • TABLE 216: Endocrine Testing Market in India: Percentage Share Breakdown of Sales by Test Type for 2012, 2020, and
    • TABLE 217: Indian Endocrine Testing Market Estimates and Forecasts in US$ Million by Endocrine Disorders: 2020 to
    • TABLE 218: Indian Endocrine Testing Historic Market Review by Endocrine Disorders in US$ Million: 2012
    • TABLE 219: Endocrine Testing Market in India: Percentage Share Breakdown of Sales by Endocrine Disorders for 2012, 2020, and
    • TABLE 220: Indian Endocrine Testing Market Estimates and Forecasts in US$ Million by Testing Technology: 2020 to
    • TABLE 221: Indian Endocrine Testing Historic Market Review by Testing Technology in US$ Million: 2012
    • TABLE 222: Endocrine Testing Market in India: Percentage Share Breakdown of Sales by Testing Technology for 2012, 2020, and
  • SOUTH KOREA
    • TABLE 223: Endocrine Testing Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020
    • TABLE 224: South Korean Endocrine Testing Historic Market Analysis in US$ Million by Test Type: 2012
    • TABLE 225: Endocrine Testing Market Share Distribution in South Korea by Test Type: 2012 VS 2020 VS
    • TABLE 226: Endocrine Testing Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 227: South Korean Endocrine Testing Historic Market Analysis in US$ Million by Endocrine Disorders: 2012
    • TABLE 228: Endocrine Testing Market Share Distribution in South Korea by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 229: Endocrine Testing Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Testing Technology for the Period 2020
    • TABLE 230: South Korean Endocrine Testing Historic Market Analysis in US$ Million by Testing Technology: 2012
    • TABLE 231: Endocrine Testing Market Share Distribution in South Korea by Testing Technology: 2012 VS 2020 VS
  • REST OF ASIA-PACIFIC
    • TABLE 232: Rest of Asia-Pacific Market for Endocrine Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020
    • TABLE 233: Endocrine Testing Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Test Type for the Period 2012
    • TABLE 234: Rest of Asia-Pacific Endocrine Testing Market Share Analysis by Test Type: 2012 VS 2020 VS
    • TABLE 235: Rest of Asia-Pacific Market for Endocrine Testing: Annual Sales Estimates and Projections in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 236: Endocrine Testing Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Endocrine Disorders for the Period 2012
    • TABLE 237: Rest of Asia-Pacific Endocrine Testing Market Share Analysis by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 238: Rest of Asia-Pacific Market for Endocrine Testing: Annual Sales Estimates and Projections in US$ Million by Testing Technology for the Period 2020
    • TABLE 239: Endocrine Testing Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Testing Technology for the Period 2012
    • TABLE 240: Rest of Asia-Pacific Endocrine Testing Market Share Analysis by Testing Technology: 2012 VS 2020 VS
  • LATIN AMERICA
    • TABLE 241: Latin American Endocrine Testing Market Trends by Region/Country in US$ Million: 2020
    • TABLE 242: Endocrine Testing Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012
    • TABLE 243: Latin American Endocrine Testing Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and
    • TABLE 244: Latin American Endocrine Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020
    • TABLE 245: Endocrine Testing Historic Market Analysis in Latin America in US$ Million by Test Type: 2012
    • TABLE 246: Latin American Endocrine Testing Marketby Test Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 247: Latin American Endocrine Testing Market Growth Prospects in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 248: Endocrine Testing Historic Market Analysis in Latin America in US$ Million by Endocrine Disorders: 2012
    • TABLE 249: Latin American Endocrine Testing Marketby Endocrine Disorders: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 250: Latin American Endocrine Testing Market Growth Prospects in US$ Million by Testing Technology for the Period 2020
    • TABLE 251: Endocrine Testing Historic Market Analysis in Latin America in US$ Million by Testing Technology: 2012
    • TABLE 252: Latin American Endocrine Testing Marketby Testing Technology: Percentage Breakdown of Sales for 2012, 2020, and
  • ARGENTINA
    • TABLE 253: Argentinean Endocrine Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020
    • TABLE 254: Endocrine Testing Market in Argentina in US$ Million by Test Type: A Historic Review for the Period 2012
    • TABLE 255: Argentinean Endocrine Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS
    • TABLE 256: Argentinean Endocrine Testing Market Estimates and Forecasts in US$ Million by Endocrine Disorders: 2020
    • TABLE 257: Endocrine Testing Market in Argentina in US$ Million by Endocrine Disorders: A Historic Review for the Period 2012
    • TABLE 258: Argentinean Endocrine Testing Market Share Breakdown by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 259: Argentinean Endocrine Testing Market Estimates and Forecasts in US$ Million by Testing Technology: 2020
    • TABLE 260: Endocrine Testing Market in Argentina in US$ Million by Testing Technology: A Historic Review for the Period 2012
    • TABLE 261: Argentinean Endocrine Testing Market Share Breakdown by Testing Technology: 2012 VS 2020 VS
  • BRAZIL
    • TABLE 262: Endocrine Testing Market in Brazil by Test Type: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 263: Brazilian Endocrine Testing Historic Market Scenario in US$ Million by Test Type: 2012
    • TABLE 264: Brazilian Endocrine Testing Market Share Analysis by Test Type: 2012 VS 2020 VS
    • TABLE 265: Endocrine Testing Market in Brazil by Endocrine Disorders: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 266: Brazilian Endocrine Testing Historic Market Scenario in US$ Million by Endocrine Disorders: 2012
    • TABLE 267: Brazilian Endocrine Testing Market Share Analysis by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 268: Endocrine Testing Market in Brazil by Testing Technology: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 269: Brazilian Endocrine Testing Historic Market Scenario in US$ Million by Testing Technology: 2012
    • TABLE 270: Brazilian Endocrine Testing Market Share Analysis by Testing Technology: 2012 VS 2020 VS
  • MEXICO
    • TABLE 271: Endocrine Testing Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020
    • TABLE 272: Mexican Endocrine Testing Historic Market Analysis in US$ Million by Test Type: 2012
    • TABLE 273: Mexican Endocrine Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS
    • TABLE 274: Endocrine Testing Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 275: Mexican Endocrine Testing Historic Market Analysis in US$ Million by Endocrine Disorders: 2012
    • TABLE 276: Mexican Endocrine Testing Market Share Breakdown by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 277: Endocrine Testing Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Testing Technology for the Period 2020
    • TABLE 278: Mexican Endocrine Testing Historic Market Analysis in US$ Million by Testing Technology: 2012
    • TABLE 279: Mexican Endocrine Testing Market Share Breakdown by Testing Technology: 2012 VS 2020 VS
  • REST OF LATIN AMERICA
    • TABLE 280: Rest of Latin America Endocrine Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to
    • TABLE 281: Endocrine Testing Market in Rest of Latin America by Test Type: A Historic Review in US$ Million for 2012
    • TABLE 282: Rest of Latin America Endocrine Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS
    • TABLE 283: Rest of Latin America Endocrine Testing Market Estimates and Projections in US$ Million by Endocrine Disorders: 2020 to
    • TABLE 284: Endocrine Testing Market in Rest of Latin America by Endocrine Disorders: A Historic Review in US$ Million for 2012
    • TABLE 285: Rest of Latin America Endocrine Testing Market Share Breakdown by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 286: Rest of Latin America Endocrine Testing Market Estimates and Projections in US$ Million by Testing Technology: 2020 to
    • TABLE 287: Endocrine Testing Market in Rest of Latin America by Testing Technology: A Historic Review in US$ Million for 2012
    • TABLE 288: Rest of Latin America Endocrine Testing Market Share Breakdown by Testing Technology: 2012 VS 2020 VS
  • MIDDLE EAST
    • TABLE 289: The Middle East Endocrine Testing Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 290: Endocrine Testing Market in the Middle East by Region/Country in US$ Million: 2012
    • TABLE 291: The Middle East Endocrine Testing Market Share Breakdown by Region/Country: 2012, 2020, and
    • TABLE 292: The Middle East Endocrine Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020 to
    • TABLE 293: The Middle East Endocrine Testing Historic Marketby Test Type in US$ Million: 2012
    • TABLE 294: Endocrine Testing Market in the Middle East: Percentage Share Breakdown of Salesby Test Type for 2012,2020, and
    • TABLE 295: The Middle East Endocrine Testing Market Estimates and Forecasts in US$ Million by Endocrine Disorders: 2020 to
    • TABLE 296: The Middle East Endocrine Testing Historic Marketby Endocrine Disorders in US$ Million: 2012
    • TABLE 297: Endocrine Testing Market in the Middle East: Percentage Share Breakdown of Salesby Endocrine Disorders for 2012,2020, and
    • TABLE 298: The Middle East Endocrine Testing Market Estimates and Forecasts in US$ Million by Testing Technology: 2020 to
    • TABLE 299: The Middle East Endocrine Testing Historic Marketby Testing Technology in US$ Million: 2012
    • TABLE 300: Endocrine Testing Market in the Middle East: Percentage Share Breakdown of Salesby Testing Technology for 2012,2020, and
  • IRAN
    • TABLE 301: Iranian Market for Endocrine Testing: Annual Sales Estimates and Projections in US$ Million by Test Type for the Period 2020
    • TABLE 302: Endocrine Testing Market in Iran: Historic Sales Analysis in US$ Million by Test Type for the Period 2012
    • TABLE 303: Iranian Endocrine Testing Market Share Analysis by Test Type: 2012 VS 2020 VS
    • TABLE 304: Iranian Market for Endocrine Testing: Annual Sales Estimates and Projections in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 305: Endocrine Testing Market in Iran: Historic Sales Analysis in US$ Million by Endocrine Disorders for the Period 2012
    • TABLE 306: Iranian Endocrine Testing Market Share Analysis by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 307: Iranian Market for Endocrine Testing: Annual Sales Estimates and Projections in US$ Million by Testing Technology for the Period 2020
    • TABLE 308: Endocrine Testing Market in Iran: Historic Sales Analysis in US$ Million by Testing Technology for the Period 2012
    • TABLE 309: Iranian Endocrine Testing Market Share Analysis by Testing Technology: 2012 VS 2020 VS
  • ISRAEL
    • TABLE 310: Israeli Endocrine Testing Market Estimates and Forecasts in US$ Million by Test Type: 2020
    • TABLE 311: Endocrine Testing Market in Israel in US$ Million by Test Type: A Historic Review for the Period 2012
    • TABLE 312: Israeli Endocrine Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS
    • TABLE 313: Israeli Endocrine Testing Market Estimates and Forecasts in US$ Million by Endocrine Disorders: 2020
    • TABLE 314: Endocrine Testing Market in Israel in US$ Million by Endocrine Disorders: A Historic Review for the Period 2012
    • TABLE 315: Israeli Endocrine Testing Market Share Breakdown by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 316: Israeli Endocrine Testing Market Estimates and Forecasts in US$ Million by Testing Technology: 2020
    • TABLE 317: Endocrine Testing Market in Israel in US$ Million by Testing Technology: A Historic Review for the Period 2012
    • TABLE 318: Israeli Endocrine Testing Market Share Breakdown by Testing Technology: 2012 VS 2020 VS
  • SAUDI ARABIA
    • TABLE 319: Saudi Arabian Endocrine Testing Market Growth Prospects in US$ Million by Test Type for the Period 2020
    • TABLE 320: Endocrine Testing Historic Market Analysis in Saudi Arabia in US$ Million by Test Type: 2012
    • TABLE 321: Saudi Arabian Endocrine Testing Market by Test Type: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 322: Saudi Arabian Endocrine Testing Market Growth Prospects in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 323: Endocrine Testing Historic Market Analysis in Saudi Arabia in US$ Million by Endocrine Disorders: 2012
    • TABLE 324: Saudi Arabian Endocrine Testing Market by Endocrine Disorders: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 325: Saudi Arabian Endocrine Testing Market Growth Prospects in US$ Million by Testing Technology for the Period 2020
    • TABLE 326: Endocrine Testing Historic Market Analysis in Saudi Arabia in US$ Million by Testing Technology: 2012
    • TABLE 327: Saudi Arabian Endocrine Testing Market by Testing Technology: Percentage Breakdown of Sales for 2012, 2020, and
  • UNITED ARAB EMIRATES
    • TABLE 328: Endocrine Testing Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020
    • TABLE 329: United Arab Emirates Endocrine Testing Historic Market Analysis in US$ Million by Test Type: 2012
    • TABLE 330: Endocrine Testing Market Share Distribution in United Arab Emirates by Test Type: 2012 VS 2020 VS
    • TABLE 331: Endocrine Testing Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 332: United Arab Emirates Endocrine Testing Historic Market Analysis in US$ Million by Endocrine Disorders: 2012
    • TABLE 333: Endocrine Testing Market Share Distribution in United Arab Emirates by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 334: Endocrine Testing Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Testing Technology for the Period 2020
    • TABLE 335: United Arab Emirates Endocrine Testing Historic Market Analysis in US$ Million by Testing Technology: 2012
    • TABLE 336: Endocrine Testing Market Share Distribution in United Arab Emirates by Testing Technology: 2012 VS 2020 VS
  • REST OF MIDDLE EAST
    • TABLE 337: Endocrine Testing Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Test Type for the Period 2020
    • TABLE 338: Rest of Middle East Endocrine Testing Historic Market Analysis in US$ Million by Test Type: 2012
    • TABLE 339: Rest of Middle East Endocrine Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS
    • TABLE 340: Endocrine Testing Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Endocrine Disorders for the Period 2020
    • TABLE 341: Rest of Middle East Endocrine Testing Historic Market Analysis in US$ Million by Endocrine Disorders: 2012
    • TABLE 342: Rest of Middle East Endocrine Testing Market Share Breakdown by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 343: Endocrine Testing Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Testing Technology for the Period 2020
    • TABLE 344: Rest of Middle East Endocrine Testing Historic Market Analysis in US$ Million by Testing Technology: 2012
    • TABLE 345: Rest of Middle East Endocrine Testing Market Share Breakdown by Testing Technology: 2012 VS 2020 VS
  • AFRICA
    • TABLE 346: African Endocrine Testing Market Estimates and Projections in US$ Million by Test Type: 2020 to
    • TABLE 347: Endocrine Testing Market in Africa by Test Type: A Historic Review in US$ Million for 2012
    • TABLE 348: African Endocrine Testing Market Share Breakdown by Test Type: 2012 VS 2020 VS
    • TABLE 349: African Endocrine Testing Market Estimates and Projections in US$ Million by Endocrine Disorders: 2020 to
    • TABLE 350: Endocrine Testing Market in Africa by Endocrine Disorders: A Historic Review in US$ Million for 2012
    • TABLE 351: African Endocrine Testing Market Share Breakdown by Endocrine Disorders: 2012 VS 2020 VS
    • TABLE 352: African Endocrine Testing Market Estimates and Projections in US$ Million by Testing Technology: 2020 to
    • TABLE 353: Endocrine Testing Market in Africa by Testing Technology: A Historic Review in US$ Million for 2012
    • TABLE 354: African Endocrine Testing Market Share Breakdown by Testing Technology: 2012 VS 2020 VS

IV. COMPETITION

  • Total Companies Profiled: 31